COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast

Clin Exp Dermatol. 2021 Oct;46(7):1344-1346. doi: 10.1111/ced.14723. Epub 2021 Jun 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / adverse effects*
  • COVID-19 Vaccines / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Phosphodiesterase 4 Inhibitors / administration & dosage
  • Phosphodiesterase 4 Inhibitors / therapeutic use
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • SARS-CoV-2 / genetics
  • Symptom Flare Up
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • COVID-19 Vaccines
  • Phosphodiesterase 4 Inhibitors
  • Thalidomide
  • apremilast